Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

GlaxoSmithKline plc Company Profile (NYSE:GSK)

Consensus Ratings for GlaxoSmithKline plc (NYSE:GSK) (?)
Ratings Breakdown: 8 Sell Rating(s), 9 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $47.00 (3.84% upside)

Current Analysts' Coverage Summary for GlaxoSmithKline plc (NYSE:GSK)
Show:
DateFirmActionRatingPrice TargetActions
5/22/2015Credit SuisseReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Berenberg BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015Bank of AmericaReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015JPMorgan Chase & Co.Reiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2015BNP ParibasReiterated RatingUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Societe GeneraleReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Liberum CapitalReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015ZacksUpgradeStrong Sell -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015BarclaysReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015Kepler Capital MarketsReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015TheStreetUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2015ArgusLower Price TargetBuy$55.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2015Panmure GordonReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015S&P Equity ResearchDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2015New Street ResearchDowngradeReduceView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Jefferies GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014Morgan StanleyReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2014Galvan ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2014Main First Bank AGDowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2014Cowen and CompanyDowngradeOutperform -> Market Perform$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2013MacquarieUpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2013 forward)